July 28, 2017 3:18 PM ET


Company Overview of Karyopharm Therapeutics Inc.

Executive Profile

Michael G. Kauffman M.D., Ph.D.

Co-Founder, Chief Executive Officer and Director, Karyopharm Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2016


Dr. Michael G. Kauffman, M.D., Ph.D., co-founded Karyopharm Therapeutics Inc. in 2008 and has been its Chief Executive Officer since January 05, 2011. Dr. Kauffman served as President at Karyopharm Therapeutics Inc. from January 2011 to December 2013 and Chief Medical Officer since December 2012 until December 2013. He serves as President of OutlineMed Inc. He served as the Consultant of Onyx Pharmaceuticals, Inc. since December 31, 2010. He served as Clinical Advisor ...

Corporate Headquarters

85 Wells Avenue
Newton, Massachusetts 02459

United States

Phone: 617-658-0600
Fax: --

Board Members Memberships

Co-Founder, Chief Executive Officer and Director
Lead Director
Independent Director


Johns Hopkins University
Johns Hopkins University
Amherst College

Other Affiliations

Annual Compensation

Total Annual Compensation$515,000

Stocks Options

All Other Compensation$11,260
Exercisable Options$666,831
Exercisable Options Value$2,507,058
Unexercisable Options$399,229
Unexercisable Options Value$904,970
Total Value of Options$3,412,027
Total Number of Options$1,066,060

Total Compensation

Total Annual Cash Compensation$773,460
Total Short Term Compensation$515,000
Other Long Term Compensation$11,260
Total Calculated Compensation$1,531,983

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Karyopharm Therapeutics Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.